The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Coronary Disease

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Coronary Disease


Psychiatry related information on Coronary Disease


High impact information on Coronary Disease


Chemical compound and disease context of Coronary Disease


Biological context of Coronary Disease


Anatomical context of Coronary Disease


Gene context of Coronary Disease


Analytical, diagnostic and therapeutic context of Coronary Disease


  1. Pathophysiology of insulin resistance in human disease. Reaven, G.M. Physiol. Rev. (1995) [Pubmed]
  2. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. Shepherd, J., Cobbe, S.M., Ford, I., Isles, C.G., Lorimer, A.R., MacFarlane, P.W., McKillop, J.H., Packard, C.J. N. Engl. J. Med. (1995) [Pubmed]
  3. A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Comuzzie, A.G., Hixson, J.E., Almasy, L., Mitchell, B.D., Mahaney, M.C., Dyer, T.D., Stern, M.P., MacCluer, J.W., Blangero, J. Nat. Genet. (1997) [Pubmed]
  4. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. Frick, M.H., Elo, O., Haapa, K., Heinonen, O.P., Heinsalmi, P., Helo, P., Huttunen, J.K., Kaitaniemi, P., Koskinen, P., Manninen, V. N. Engl. J. Med. (1987) [Pubmed]
  5. Coffee, alcohol and risk of coronary heart disease among Japanese men living in Hawaii. Yano, K., Rhoads, G.G., Kagan, A. N. Engl. J. Med. (1977) [Pubmed]
  6. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. LaRosa, J.C., He, J., Vupputuri, S. JAMA (1999) [Pubmed]
  7. Effects of life-style modification on serum lipids. Barnard, R.J. Arch. Intern. Med. (1991) [Pubmed]
  8. Depressive symptoms and 24-hour urinary norepinephrine excretion levels in patients with coronary disease: findings from the Heart and Soul Study. Otte, C., Neylan, T.C., Pipkin, S.S., Browner, W.S., Whooley, M.A. The American journal of psychiatry. (2005) [Pubmed]
  9. Short-term benefit of smoking cessation in patients with coronary heart disease: estimates based on self-reported smoking data and serum cotinine measurements. Twardella, D., Küpper-Nybelen, J., Rothenbacher, D., Hahmann, H., Wüsten, B., Brenner, H. Eur. Heart J. (2004) [Pubmed]
  10. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Pajukanta, P., Lilja, H.E., Sinsheimer, J.S., Cantor, R.M., Lusis, A.J., Gentile, M., Duan, X.J., Soro-Paavonen, A., Naukkarinen, J., Saarela, J., Laakso, M., Ehnholm, C., Taskinen, M.R., Peltonen, L. Nat. Genet. (2004) [Pubmed]
  11. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. Brown, B.G., Zhao, X.Q., Chait, A., Fisher, L.D., Cheung, M.C., Morse, J.S., Dowdy, A.A., Marino, E.K., Bolson, E.L., Alaupovic, P., Frohlich, J., Albers, J.J. N. Engl. J. Med. (2001) [Pubmed]
  12. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. Herrington, D.M., Reboussin, D.M., Brosnihan, K.B., Sharp, P.C., Shumaker, S.A., Snyder, T.E., Furberg, C.D., Kowalchuk, G.J., Stuckey, T.D., Rogers, W.J., Givens, D.H., Waters, D. N. Engl. J. Med. (2000) [Pubmed]
  13. Normalization on triglycerides in type IV hyperlipoproteinemia fails to correct low levels of high-density-lipoprotein cholesterol. Witztum, J.L., Dillingham, M.A., Giese, W., Bateman, J., Diekman, C., Blaufuss, E.K., Weidman, S., Schonfeld, G. N. Engl. J. Med. (1980) [Pubmed]
  14. A prospective study of postmenopausal estrogen therapy and coronary heart disease. Stampfer, M.J., Willett, W.C., Colditz, G.A., Rosner, B., Speizer, F.E., Hennekens, C.H. N. Engl. J. Med. (1985) [Pubmed]
  15. Plasma triglyceride levels and coronary disease. Brunzell, J.D., Austin, M.A. N. Engl. J. Med. (1989) [Pubmed]
  16. Plasma homocysteine levels and mortality in patients with coronary artery disease. Nygård, O., Nordrehaug, J.E., Refsum, H., Ueland, P.M., Farstad, M., Vollset, S.E. N. Engl. J. Med. (1997) [Pubmed]
  17. Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group. Johannesson, M., Jönsson, B., Kjekshus, J., Olsson, A.G., Pedersen, T.R., Wedel, H. N. Engl. J. Med. (1997) [Pubmed]
  18. Mortality rates and risk factors for coronary disease in black as compared with white men and women. Keil, J.E., Sutherland, S.E., Knapp, R.G., Lackland, D.T., Gazes, P.C., Tyroler, H.A. N. Engl. J. Med. (1993) [Pubmed]
  19. Reflex increase in coronary vascular resistance in patients with ischemic heart disease. Mudge, G.H., Grossman, W., Mills, R.M., Lesch, M., Braunwald, E. N. Engl. J. Med. (1976) [Pubmed]
  20. Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. Hulley, S.B., Rosenman, R.H., Bawol, R.D., Brand, R.J. N. Engl. J. Med. (1980) [Pubmed]
  21. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. Godsland, I.F., Crook, D., Simpson, R., Proudler, T., Felton, C., Lees, B., Anyaoku, V., Devenport, M., Wynn, V. N. Engl. J. Med. (1990) [Pubmed]
  22. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. Griselli, M., Herbert, J., Hutchinson, W.L., Taylor, K.M., Sohail, M., Krausz, T., Pepys, M.B. J. Exp. Med. (1999) [Pubmed]
  23. Neutrophil adherence to isolated adult cardiac myocytes. Induction by cardiac lymph collected during ischemia and reperfusion. Youker, K., Smith, C.W., Anderson, D.C., Miller, D., Michael, L.H., Rossen, R.D., Entman, M.L. J. Clin. Invest. (1992) [Pubmed]
  24. Linoleic and eicosapentaenoic acids in adipose tissue and platelets and risk of coronary heart disease. Wood, D.A., Riemersma, R.A., Butler, S., Thomson, M., Macintyre, C., Elton, R.A., Oliver, M.F. Lancet (1987) [Pubmed]
  25. Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: a case-cohort study. Salomaa, V., Matei, C., Aleksic, N., Sansores-Garcia, L., Folsom, A.R., Juneja, H., Chambless, L.E., Wu, K.K. Lancet (1999) [Pubmed]
  26. Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Saito, I., Folsom, A.R., Brancati, F.L., Duncan, B.B., Chambless, L.E., McGovern, P.G. Ann. Intern. Med. (2000) [Pubmed]
  27. Determinants of severity of coronary artery disease in Australian men and women. Wang, X.L., Tam, C., McCredie, R.M., Wilcken, D.E. Circulation (1994) [Pubmed]
  28. Paraoxonase and coronary heart disease. Mackness, M.I., Mackness, B., Durrington, P.N. Atherosclerosis. Supplements. (2002) [Pubmed]
  29. Relation of parental history of early myocardial infarction to the level of apoprotein B in men. Cambien, F., Warnet, J.M., Jacqueson, A., Ducimetiere, P., Richard, J.L., Claude, J.R. Circulation (1987) [Pubmed]
  30. Haplotypic analyses of the IGF2-INS-TH gene cluster in relation to cardiovascular risk traits. Rodríguez, S., Gaunt, T.R., O'Dell, S.D., Chen, X.H., Gu, D., Hawe, E., Miller, G.J., Humphries, S.E., Day, I.N. Hum. Mol. Genet. (2004) [Pubmed]
  31. Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport. Bruce, C., Chouinard, R.A., Tall, A.R. Annu. Rev. Nutr. (1998) [Pubmed]
  32. Genetics of HDL regulation in humans. Miller, M., Rhyne, J., Hamlette, S., Birnbaum, J., Rodriguez, A. Curr. Opin. Lipidol. (2003) [Pubmed]
  33. Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. McFadden, E.P., Clarke, J.G., Davies, G.J., Kaski, J.C., Haider, A.W., Maseri, A. N. Engl. J. Med. (1991) [Pubmed]
  34. Impaired chronotropic response to exercise stress testing as a predictor of mortality. Lauer, M.S., Francis, G.S., Okin, P.M., Pashkow, F.J., Snader, C.E., Marwick, T.H. JAMA (1999) [Pubmed]
  35. Alpha adrenergic contributions to dysrhythmia during myocardial ischemia and reperfusion in cats. Sheridan, D.J., Penkoske, P.A., Sobel, B.E., Corr, P.B. J. Clin. Invest. (1980) [Pubmed]
  36. Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial. Ganz, P.A., Day, R., Ware, J.E., Redmond, C., Fisher, B. J. Natl. Cancer Inst. (1995) [Pubmed]
  37. Plasma cholesterol and depressive symptoms in older men. Morgan, R.E., Palinkas, L.A., Barrett-Connor, E.L., Wingard, D.L. Lancet (1993) [Pubmed]
WikiGenes - Universities